abagovomab 34
abciximab 30
abituzumab 24
abrilumab 22
actoxumab 16
adalimumab 17
aducanumab 15
afasevikumab 18
alacizumab_pegol 11
alemtuzumab 32
alirocumab 25
amatuximab 43
andecaliximab 24
anifrolumab 22
anrukinzumab 17
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 19
ascrinvacumab 7
atezolizumab 16
atinumab 18
avelumab 16
basiliximab 32
bavituximab 38
begelomab 26
benralizumab 30
bevacizumab_beta 23
bezlotoxumab 16
bimagrumab 19
bleselumab 24
blinatumomab 33
blosozumab 30
bococizumab 19
brazikumab 19
brentuximab_vedotin 34
briakinumab 20
brodalumab 14
brolucizumab 28
brontictuzumab 30
burosumab 22
cabiralizumab 30
camrelizumab 15
canakinumab 24
cantuzumab_ravtansin 43
carlumab 18
carotuximab 24
cergutuzumab_amunaleukin2 26
cergutuzumab_amunaleukin 26
certolizumab_pegol 27
cetiximab 43
citatuzumab_bogatox 28
cixutumumab 29
clivatuzumab_tetraxetan 22
codrituzumab 32
conatumumab 17
concizumab 29
crenezumab 23
crizanlizumab 28
crotedumab 23
dacetuzumab 24
daclizumab 18
dalotuzumab 32
dapirolizumab_pegol 27
daratumumab 15
dectrekumab 11
demcizumab 25
denosumab 9
depatuxizumab 24
depatuxizumab_mafodotin 24
dezamizumab 24
dinutuximab 33
diridavumab 23
domagrozumab 18
drozitumab 21
duligotuzumab 20
durvalumab 15
dusigitumab 23
efalizumab 37
efungumab 29
eldelumab 20
elezanumab 23
elgemtumab 14
elotuzumab 18
emactuzumab 22
emapalumab 31
emibetuzumab 20
enavatuzumab 26
enfortumab_vedotin 15
enoblituzumab 19
enokizumab 26
enoticumab 22
ensituximab 38
eptinezumab 18
erenumab 25
etaracizumab 15
etrolizumab 23
evinacumab 24
evolocumab 18
farletuzumab 3
fasinumab 24
fezakinumab 25
fibatuzumab 14
ficlatuzumab 25
firivumab 31
flanvotumab 21
fletikumab 31
foralumab 15
foravirumab 17
fremanezumab 30
fresolimumab 16
fulranumab 22
futuximab 21
galcanezumab 20
ganitumab 22
gantenerumab 15
gemetuzumab 32
gemtuzumab2 29
gemtuzumab 27
gevokizumab 24
girentuximab 31
glembatumumab 19
glembatumumab_vedotin 19
guselkumab 21
ibalizumab 29
ibritumomab 33
icrucumab 14
idarucizumab 32
ifabotuzumab 14
imalumab 18
imgatuzumab 24
inclacumab 24
indatuximab_ravtansin 28
indusatumab 19
inebilizumab 25
intetumumab 17
iodine_girentuximab 31
ipilimumab 11
iratumumab 18
isatuximab 36
itolizumab 23
ixekizumab 33
labetuzumab_govitecan 26
lambrolizumab 31
lampalizumab 27
lanadelumab 19
landogrozumab 19
laprituximab 31
lebrikizumab 37
lendalizumab 27
lenzilumab 20
lifastuzumab_vedotin 25
ligelizumab 23
lilotomab 39
lirilumab 29
lodelcizumab 21
lokivetmab 25
lorvotuzumab_mertansin 24
lucatumumab 32
lumretuzumab 19
lupartumab 19
lutikizumab 19
margetuximab 34
milatuzumab 39
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 42
mogamulizumab 29
monalizumab 24
motavizumab 35
moxetumomab_pasudotox 26
namilumab 24
naratuximab 33
naratuximab_emtansin 33
narnatumab 20
navicixizumab2 28
navicixizumab 27
navivumab 34
necitumumab 11
nemolizumab 27
nesvacumab 17
nivolumab 13
obiltoxaximab 21
obinutuzumab 32
ocaratuzumab 24
ofatumumab 20
olaratumab 19
olokizumab 24
omalizumab 22
onartuzumab 24
ontuxizumab 35
opicinumab 15
orticumab 14
otelixizumab 39
oxelumab 14
ozanezumab 34
pamrevlumab 14
panobacumab 25
parsatuzumab 31
pasotuxizumab 22
pateclizumab 19
patritumab 22
pembrolizumab 31
perakizumab 24
pidilizumab 21
pinatuzumab_vedotin 19
plozalizumab 27
pogalizumab 28
polatuzumab_vedotin 22
ponezumab 35
prezalumab 17
pritoxaximab 39
quilizumab 21
racotumomab 31
radretumab 18
ralpancizumab 24
ramucirumab 14
ranevetmab 33
ranibizumab 23
refanezumab 25
remtolumab 20
rilotumumab 15
rinucumab 17
risankizumab 32
rituximab 24
rivabazumab 24
robatumumab 20
roledumab 33
romosozumab 22
rontalizumab 26
rosmantuzumab 23
rozanolixizumab 24
sacituzumab 29
sacituzumab_govitecan 29
samalizumab 29
sapelizumab 24
sarilumab 18
secukinumab 18
seribantumab 16
setoxaximab 44
sifalimumab 14
siltuximab 22
simtuzumab 30
sirukumab 14
solanezumab 29
solitomab 28
stamulumab 19
suptavumab 26
suvizumab 21
tabalumab 21
tadocizumab 21
tamtuvetmab 36
tanezumab 24
tarextumab 12
tavolixizumab 13
telisotuzumab 31
teplizumab 25
tesidolumab 26
tezepelumab 31
tigatuzumab 17
tildrakizumab 24
timolumab 17
tisotumab 11
tosatoxumab 35
tositumomab 30
tralokinumab 34
trastuzumab 24
tregalizumab 22
trevogrumab 12
ublituximab 28
urelumab 22
ustekinumab 29
utomilumab 26
vadastuximab 29
vadastuximab_talirin 29
vandortuzumab_vedotin 23
vantictumab 21
vanucizumab2 23
vanucizumab 36
varlilumab 18
vatelizumab 22
vedolizumab 29
veltuzumab 17
vesencumab 11
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 32
xentuzumab 19
zatuximab 42
